person

Josep M. M.

Country
Spain
Department
Unitat de VIH-SIDA

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
94
Sites with multiple studies

Has run more than one trial at 94 of 156 partner sites.

Specializations

HIV Treatment Innovation

This investigator specializes in evaluating novel therapeutic approaches for HIV-1 infection, with particular focus on comparing the effectiveness of dual-drug versus triple-drug regimens. Their research explores both treatment-naïve patients and those switching from existing therapies.

  • Antiretroviral combination therapies
  • Treatment optimization strategies
  • Viral suppression efficacy

Their work encompasses the evaluation of innovative drug combinations including doravirine/islatravir and bictegravir-based regimens.

Treatment Simplification Studies

The investigator conducts research on simplifying HIV treatment regimens, including the development of weekly oral dosing options and fixed-dose combinations. Their studies examine the potential of reducing pill burden while maintaining therapeutic efficacy.

  • Weekly dosing protocols
  • Fixed-dose combinations
  • Long-acting formulations

A key focus is the evaluation of lenacapavir-based treatments and their potential in simplifying HIV therapy.

Therapeutic Innovation

The investigator's research portfolio includes work on immunological approaches to HIV treatment, including novel therapeutic vaccines and immune modulation strategies. They study both conventional antiretroviral therapy and emerging treatment modalities.

  • Vaccine development
  • Immunological interventions
  • Treatment-experienced patient care

Their work includes evaluation of SOSIP vaccine candidates and immune-based therapeutic approaches.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.